Cargando…
Human macrophages limit oxidation products in low density lipoprotein
This study tested the hypothesis that human macrophages have the ability to modify oxidation products in LDL and oxidized LDL (oxLDL) via a cellular antioxidant defence system. While many studies have focused on macrophage LDL oxidation in atherosclerosis development, less attention has been given t...
Autores principales: | Hultén, Lillemor Mattsson, Ullström, Christina, Krettek, Alexandra, van Reyk, David, Marklund, Stefan L, Dahlgren, Claes, Wiklund, Olov |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555960/ https://www.ncbi.nlm.nih.gov/pubmed/15745457 http://dx.doi.org/10.1186/1476-511X-4-6 |
Ejemplares similares
-
Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction
por: Abdo, Adrian I., et al.
Publicado: (2017) -
Arachidonate 15-Lipoxygenase Type B Knockdown Leads to Reduced Lipid Accumulation and Inflammation in Atherosclerosis
por: Magnusson, Lisa U., et al.
Publicado: (2012) -
Regulation and splicing of scavenger receptor class B type I in human macrophages and atherosclerotic plaques
por: Svensson, Per-Arne, et al.
Publicado: (2005) -
Vimentin deficiency in macrophages induces increased oxidative stress and vascular inflammation but attenuates atherosclerosis in mice
por: Håversen, Liliana, et al.
Publicado: (2018) -
The variation in free 25-hydroxy vitamin D and vitamin D-binding protein with season and vitamin D status
por: Oleröd, Göran, et al.
Publicado: (2017)